Chemical inhibitors of 1700020L24Rik can impede its function through various mechanisms involving the inhibition of kinases that are crucial for its phosphorylation and activation. Staurosporine serves as a broad-spectrum protein kinase inhibitor, which can prevent the phosphorylation process essential for the activation of 1700020L24Rik. Similarly, Dasatinib and PP2, both Src family kinase inhibitors, target kinases that are responsible for key phosphorylation events necessary for the functional activity of 1700020L24Rik. These inhibitors block the catalytic activity of the kinases, thereby inhibiting the phosphorylation that would otherwise activate 1700020L24Rik. ZM-447439, which targets Aurora kinases, impedes cell cycle-related processes that are integral for the function of this protein. By inhibiting these kinases, ZM-447439 can suppress the cellular events that are necessary for the proper functioning of 1700020L24Rik.
Additionally, the inhibition of specific signaling pathways provides another avenue to inhibit 1700020L24Rik. Wortmannin and LY294002 both inhibit PI3K, which is a pivotal molecule in the PI3K/Akt pathway, a pathway that can include the activation of 1700020L24Rik as part of its downstream effects. The inhibition of this pathway by Wortmannin and LY294002 prevents the subsequent activation of 1700020L24Rik. PD98059 and U0126 specifically target MEK1/2, which are upstream in the ERK pathway signaling cascade. The ERK pathway is another potential contributor to the phosphorylation and activation of 1700020L24Rik, and its inhibition by these chemicals disrupts this influence. SB203580 and SP600125 target the p38 MAP kinase and JNK, respectively, both of which are part of stress-activated kinase pathways. Their inhibition can interrupt signaling that would normally involve the activation of 1700020L24Rik. Rapamycin, as an mTOR inhibitor, blocks a central regulatory pathway that can control the activity of 1700020L24Rik. By inhibiting mTOR, Rapamycin can suppress the function of 1700020L24Rik through the disruption of downstream signaling pathways. Each chemical inhibitor contributes to the suppression of 1700020L24Rik by targeting specific proteins or pathways that are necessary for its activity within the cell.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
As a broad-spectrum protein kinase inhibitor, Staurosporine can inhibit kinases that phosphorylate 1700020L24Rik, thereby inhibiting its function. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin, a PI3K inhibitor, can inhibit the PI3K/Akt pathway, which is necessary for the phosphorylation and activation of 1700020L24Rik. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is another PI3K inhibitor that, by obstructing PI3K, can prevent activation of downstream targets that may include 1700020L24Rik. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
This PKC inhibitor can inhibit Protein Kinase C, which is potentially involved in signaling pathways necessary for 1700020L24Rik activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 inhibits MEK1, which interferes with the ERK pathway, a pathway necessary for the phosphorylation and thus inhibition of 1700020L24Rik. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 inhibits MEK1/2, which are upstream of ERK pathway signaling; ERK is potentially necessary for 1700020L24Rik activation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 selectively inhibits p38 MAP kinase, disrupting signaling that can inhibit the activation of 1700020L24Rik. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
As an mTOR inhibitor, Rapamycin can inhibit mTOR signaling pathways, which may be essential for 1700020L24Rik's function. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits JNK, which can inhibit signaling processes that involve 1700020L24Rik, affecting its functional activity. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib, a Src family kinase inhibitor, can inhibit kinases necessary for the phosphorylation and activation of 1700020L24Rik. | ||||||